Clinical trials of deep vein thrombosis prophylaxis in medical patients (Q36499130)

14 August 2017

1 reference

title

Clinical trials of deep vein thrombosis prophylaxis in medical patients (English)

1 reference

14 August 2017

0 references

1 reference

1

Walter Ageno

1 reference

14 August 2017

Alexander G G Turpie

2

1 reference

14 August 2017

publication date

1 January 2005

1 reference

14 August 2017

1 reference

14 August 2017

volume

7

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

16-22

1 reference

Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

Risk factors for pulmonary embolism. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

Incidence of venous thromboembolism verified by necropsy over 30 years

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review.

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

Prevention of deep vein thrombosis in medical patients by low-dose heparin

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis.

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

High risk of the critically ill for venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group.

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

Heparin prophylaxis in bedridden patients

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial

1 reference

https://api.crossref.org/works/10.1016/S1098-3597(05)80099-7

7 January 2021

10.1016/S1098-3597(05)80099-7

Identifiers

DOI

1 reference

14 August 2017

1 reference